122 related articles for article (PubMed ID: 6242320)
1. [Immunotherapy of malignant tumors with subpopulations of T lymphocytes].
Fernández-Cruz E
Rev Esp Oncol; 1982; 29(4):701-10. PubMed ID: 6242320
[TBL] [Abstract][Full Text] [Related]
2. Induction of Moloney murine sarcoma virus tolerance in adult mice by anti-CD4 monoclonal antibody treatment.
Biasi G; Mazzocchi M; Facchinetti A; Panozzo M; Zanovello P; Collavo D; Chieco-Bianchi L
Cancer Res; 1990 Sep; 50(17 Suppl):5703S-5706S. PubMed ID: 2167167
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of a chemically-induced sarcoma in rats: characterization of the effector T cell subset and nature of suppression.
Fernandez-Cruz E; Gilman SC; Feldman JD
J Immunol; 1982 Mar; 128(3):1112-7. PubMed ID: 6460058
[TBL] [Abstract][Full Text] [Related]
4. Altered levels of mononuclear leukocytes in tumor-bearing rats: decrease of helper T lymphocytes and increase of suppressor cells.
Fernandez-Cruz E; Gilman SC; Feldman JD
J Immunol; 1982 Sep; 129(3):1324-8. PubMed ID: 6213711
[TBL] [Abstract][Full Text] [Related]
5. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
6. Primary chemically induced tumors induce profound immunosuppression concomitant with apoptosis and alterations in signal transduction in T cells and NK cells.
Horiguchi S; Petersson M; Nakazawa T; Kanda M; Zea AH; Ochoa AC; Kiessling R
Cancer Res; 1999 Jun; 59(12):2950-6. PubMed ID: 10383160
[TBL] [Abstract][Full Text] [Related]
7. Suppression of allograft rejection in the rat by pretreatment with cells of the T-helper, but not T-cytotoxic suppressor phenotype.
Cranston D; Wood KJ; Carter NP; Morris PJ
Transplant Proc; 1987 Feb; 19(1 Pt 1):505. PubMed ID: 2978918
[No Abstract] [Full Text] [Related]
8. [Tumor-specific immunotherapy: active immunotherapy by augmenting the induction of tumor-specific effector T cells through a T-T cell interaction mechanism].
Kosugi A; Fujiwara H; Hamaoka T
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1527-35. PubMed ID: 6236750
[TBL] [Abstract][Full Text] [Related]
9. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor.
Matsumura T; Krinock RA; Chang AE; Shu S
Cancer Res; 1993 Sep; 53(18):4315-21. PubMed ID: 8364926
[TBL] [Abstract][Full Text] [Related]
10. Subsets of circulating T-lymphocytes mediating resistance to in vivo growth of a carcinogen-induced syngeneic rat tumor.
Crum ED
Cancer Res; 1984 Aug; 44(8):3196-201. PubMed ID: 6234986
[TBL] [Abstract][Full Text] [Related]
11. Effect of macrophages and antibodies on in vivo growth of Moloney sarcoma in the rat.
Miller GA; Feldman JD
J Immunol; 1977 Oct; 119(4):1445-51. PubMed ID: 302284
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of human T4+ inducer T cells defined by a monoclonal antibody that delineates two functional subpopulations.
Reinherz EL; Morimoto C; Fitzgerald KA; Hussey RE; Daley JF; Schlossman SF
J Immunol; 1982 Jan; 128(1):463-8. PubMed ID: 6459376
[TBL] [Abstract][Full Text] [Related]
13. Aberrant T helper cell response in tumor-bearing mice limits the efficacy of dendritic cell vaccine.
Kao JY; Zhang M; Chen CM; Pierzchala A; Chen JJ
Immunol Lett; 2006 May; 105(1):16-25. PubMed ID: 16388858
[TBL] [Abstract][Full Text] [Related]
14. CD4+ T lymphocytes play a critical role in antibody production and tumor immunity against simian virus 40 large tumor antigen.
Kennedy RC; Shearer MH; Watts AM; Bright RK
Cancer Res; 2003 Mar; 63(5):1040-5. PubMed ID: 12615720
[TBL] [Abstract][Full Text] [Related]
15. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer.
Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M
Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492
[TBL] [Abstract][Full Text] [Related]
16. Local administration of interleukin-2 activates lymphocytes from tumor bearing mice to recruit host immunoreactivity and inhibit tumor growth.
Forni G; Musso T; Santoni A; Giovarelli M
Prog Clin Biol Res; 1987; 244():105-14. PubMed ID: 2958866
[No Abstract] [Full Text] [Related]
17. Stimulation of secondary anti-MSV cytolytic T lymphocytes with MBL-2 reconstituted membranes.
Duprez V; Mescher MF; Burakoff SJ
J Immunol; 1983 Jan; 130(1):493-5. PubMed ID: 6600194
[TBL] [Abstract][Full Text] [Related]
18. Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4.
Prigent P; Saoudi A; Pannetier C; Graber P; Bonnefoy JY; Druet P; Hirsch F
J Clin Invest; 1995 Sep; 96(3):1484-9. PubMed ID: 7657819
[TBL] [Abstract][Full Text] [Related]
19. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
[TBL] [Abstract][Full Text] [Related]
20. In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes.
Hwu P; Yang JC; Cowherd R; Treisman J; Shafer GE; Eshhar Z; Rosenberg SA
Cancer Res; 1995 Aug; 55(15):3369-73. PubMed ID: 7614473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
